37.60 -1.66 (-4.23%)

33.88% Fall from 52W High

568.0K XNAS Volume

XNAS 07 May, 2025 5:30 PM (EDT)

Board Meeting
The board meeting for MoonLake Immunotherapeutics - Ordinary Shares - Class A is scheduled for today, for the purpose of MoonLake Immunotherapeutics First Quarter Earnings Results for 2025 See details